Monopar cut to Neutral at Cantor on valuation
Reported by Seeking Alpha · seekingalpha.com · August 13, 2026
Monopar Therapeutics (MNPR) stock dips as Cantor Fitzgerald downgrades the company to Neutral from Overweight on valuation after its recent rally. Read more here.
What the tape says
What to watch: MNPR (MNPR) was downgraded by an analyst — check whether the thesis change is fundamental or just a valuation call.
Market reaction today: $MNPR +3.38%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.